
BYK191023 dihydrochloride
CAS No. 1216722-25-6
BYK191023 dihydrochloride( BYK-191023 )
Catalog No. M10811 CAS No. 1216722-25-6
BYK191023 dihydrochloride (BYK-191023) is a potent, highly selective inhibitor of inducible nitric-oxide synthase (iNOS) with IC50 of 86 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBYK191023 dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionBYK191023 dihydrochloride (BYK-191023) is a potent, highly selective inhibitor of inducible nitric-oxide synthase (iNOS) with IC50 of 86 nM.
-
DescriptionBYK191023 dihydrochloride (BYK-191023) is a potent, highly selective inhibitor of inducible nitric-oxide synthase (iNOS) with IC50 of 86 nM, >20-fold selectivity over nNOS and eNOS (IC50=17 and 162 uM); exhibits an affinity for iNOS, nNOS, and eNOS of 450 nM, 30 uM, and >500 uM, respectively; inhibits cellular nitrate/nitrite synthesis in RAW, rat mesangium, and human embryonic kidney 293 cells with IC50 values 40- to 100-fold higher than at the isolated enzyme; dose-dependently suppresses the LPS-induced increase in plasma nitrate/nitrite (NO(x)) levels with ED50 of 14.9 micromol/kg/h, partially restores normal blood pressure responses to norepinephrine and sodium nitroprusside in model of LPS-induced vascular hyporesponsiveness.
-
In Vitro——
-
In Vivo——
-
SynonymsBYK-191023
-
PathwayImmunology/Inflammation
-
TargetNOS
-
RecptorNOS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1216722-25-6
-
Formula Weight327.209
-
Molecular FormulaC14H16Cl2N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=CC(CCC2=NC3=NC=CC=C3N2)=NC=C1.[H]Cl.[H]Cl
-
Chemical Name2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine dihydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Strub A, et al. Mol Pharmacol. 2006 Jan;69(1):328-37.
2. Lehner MD, et al. J Pharmacol Exp Ther. 2006 Apr;317(1):181-7.
3. Tiso M, et al. Mol Pharmacol. 2008 Apr;73(4):1244-53.
4. Higashi Y, et al. Br J Pharmacol. 2018 Jul 14. doi: 10.1111/bph.14445.
molnova catalog



related products
-
Stylopine hydrochlor...
Stylopine is a protoberberine-type alkaloid that has potential biological activities including anti-inflammatory activity.
-
S-(2-aminoethyl) Iso...
S-(2-aminoethyl) Isothiourea (dihydrobromide) is a non-selective inhibitor of all NOS isoforms. For human nNOS eNOS and iNOS the Ki values are 1.8 2.1 and 0.59 μM respectively.
-
S-Nitroso-N-acetyl-D...
S-Nitroso-N-acetyl-DL-penicillamine acts as a stable inhibitor of platelet aggregation, is a nitric oxide donor and . S-Nitroso-N-acetyl-DL-penicillamine (10 mM; 8 hours) after 6 hours under normoxic conditions by releasing nitric oxide (NO)induces toxicity of about 80% .